LeMaitre Vascular, Inc. is a provider of medical devices for the treatment of peripheral vascular disease. The Company develops, manufactures and markets medical devices and implants used primarily in the field of vascular surgery. It is engaged in the design, marketing, sales and technical support of medical devices and implants for the treatment of peripheral vascular disease industry segment. The Company's product lines include valvulotomes, balloon catheters, carotid shunts, biologic vascular patches, radiopaque marking tape, anastomotic clips, remote endarterectomy devices, laparoscopic cholecystectomy devices, prosthetic vascular grafts, biologic vascular grafts and powered phlebectomy devices. Its portfolio of peripheral vascular devices consists of brand name products that are used in arteries and veins outside of the heart, including the Expandable LeMaitre Valvulotome, the Pruitt F3 Carotid Shunt, VascuTape Radiopaque Tape and the XenoSure biologic patch.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Advanced Medical Equipment & Technology - NEC
- Sub-Industry: N/A
- Symbol: NASDAQ:LMAT
- CUSIP: N/A
- Web: www.lemaitre.com
Capitalization:- Market Cap: $534.18 million
- Outstanding Shares: 18,809,000
Average Prices:- 50 Day Moving Avg: $29.51
- 200 Day Moving Avg: $26.63
- 52 Week Range: $15.87 - $33.22
P/E:- Trailing P/E Ratio: 48.25
- Foreward P/E Ratio: 35.06
- P/E Growth: 2.78
Sales & Book Value:- Annual Revenue: $93.03 million
- Price / Sales: 5.74
- Book Value: $4.90 per share
- Price / Book: 5.80
Dividend:- Annual Dividend: $0.22
- Dividend Yield: 0.8%
Profitability:- EBIDTA: $21.22 million
- Net Margins: 12.52%
- Return on Equity: 13.36%
- Return on Assets: 11.49%
Debt:- Current Ratio: 5.81%
- Quick Ratio: 3.89%
Misc:- Average Volume: 209,165 shs.
- Beta: 0.63
- Short Ratio: 3.51
Frequently Asked Questions for LeMaitre Vascular (NASDAQ:LMAT)
What is LeMaitre Vascular's stock symbol?
LeMaitre Vascular trades on the NASDAQ under the ticker symbol "LMAT."
How often does LeMaitre Vascular pay dividends? What is the dividend yield for LeMaitre Vascular?
LeMaitre Vascular announced a quarterly dividend on Friday, April 28th. Investors of record on Wednesday, May 24th will be given a dividend of $0.055 per share on Thursday, June 8th. This represents a $0.22 dividend on an annualized basis and a dividend yield of 0.77%. The ex-dividend date is Monday, May 22nd. View LeMaitre Vascular's Dividend History.
How were LeMaitre Vascular's earnings last quarter?
LeMaitre Vascular, Inc. (NASDAQ:LMAT) released its quarterly earnings data on Wednesday, October, 26th. The company reported $0.17 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $0.15 by $0.02. The company earned $19 million during the quarter, compared to the consensus estimate of $22.20 million. LeMaitre Vascular had a net margin of 12.52% and a return on equity of 13.36%. The company's revenue for the quarter was up 22.1% on a year-over-year basis. During the same quarter last year, the firm posted $0.11 EPS. View LeMaitre Vascular's Earnings History.
Where is LeMaitre Vascular's stock going? Where will LeMaitre Vascular's stock price be in 2017?
8 analysts have issued twelve-month price objectives for LeMaitre Vascular's shares. Their forecasts range from $20.00 to $31.00. On average, they expect LeMaitre Vascular's share price to reach $25.71 in the next twelve months. View Analyst Ratings for LeMaitre Vascular.
What are analysts saying about LeMaitre Vascular stock?
Here are some recent quotes from research analysts about LeMaitre Vascular stock:
- 1. According to Zacks Investment Research, "LEMAITRE VASCULAR, INC. is a leading global provider of innovative devices for the treatment of peripheral vascular disease. LeMaitre develops, manufactures, and markets disposable and implantable vascular devices to address the needs of vascular surgeons and interventionalists. LeMaitre's diversified product portfolio consists of twelve well-known brand name products used in arteries and veins outside of the heart and are supported by a growing, specialized and highly trained organization of vascular sales professionals. LeMaitre Vascular offers a wide range of innovative products to vascular surgeons and interventionalists for improving procedure efficacy and minimizing patient recovery time. " (7/4/2017)
- 2. Canaccord Genuity analysts commented, "We view this event as largely priced in, given the previous success in narcolepsy in a Phase II trial and a successful read-out from two Phase III trials in excessive sleepiness (ES) associated with obstructive sleep apnea (OSA). We currently model an 80% probability of approval and risk-adjusted sales of $558.9 million in 2026." (4/27/2017)
Who are some of LeMaitre Vascular's key competitors?
Some companies that are related to LeMaitre Vascular include Mazor Robotics (MZOR), Luminex Corporation (LMNX), GenMark Diagnostics (GNMK), Accuray Incorporated (ARAY), Corindus Vascular Robotics (CVRS), Pacific Biosciences of California (PACB), ViewRay (VRAY), Alliance HealthCare Services (AIQ), Cytosorbents Corporation (CTSO), Viveve Medical (VIVE), FULGENT GENETIC (FLGT), Cogentix Medical (CGNT), IRIDEX Corporation (IRIX), Harvard Bioscience (HBIO), Edap Tms S.A. (EDAP), Neovasc (NVCN), Digirad Corporation (DRAD) and Biolase (BIOL).
Who are LeMaitre Vascular's key executives?
LeMaitre Vascular's management team includes the folowing people:
- George W. LeMaitre, Chairman of the Board, Chief Executive Officer
- David B. Roberts, President, Director
- Joseph P. Pellegrino Jr., Chief Financial Officer, Director
- Peter R. Gebauer, President - International Operations
- Trent G. Kamke, Senior Vice President - Operations
- Cornelia W. LeMaitre, Vice President - Human Resources
- Lawrence J. Jasinski, Independent Director
- John J. O'Connor, Independent Director
- John A. Roush, Independent Director
- Michael H. Thomas, Independent Director
Who owns LeMaitre Vascular stock?
LeMaitre Vascular's stock is owned by a number of of retail and institutional investors. Top institutional investors include Conestoga Capital Advisors LLC (3.00%), Thomson Horstmann & Bryant Inc. (1.95%), Summit Creek Advisors LLC (1.07%), Russell Investments Group Ltd. (0.84%), Perkins Capital Management Inc. (0.45%) and Congress Asset Management Co. MA (0.18%). Company insiders that own LeMaitre Vascular stock include Cornelia W Lemaitre, David B Roberts, George W Lemaitre, Joseph P Pellegrino, Jr, Lawrence J Jasinski, Michael T Wijas, Peter R Gebauer and Trent G Kamke. View Institutional Ownership Trends for LeMaitre Vascular.
Who sold LeMaitre Vascular stock? Who is selling LeMaitre Vascular stock?
LeMaitre Vascular's stock was sold by a variety of institutional investors in the last quarter, including Perkins Capital Management Inc., Summit Creek Advisors LLC, Strs Ohio, First Quadrant L P CA and Bank of Montreal Can. Company insiders that have sold LeMaitre Vascular stock in the last year include Cornelia W Lemaitre, David B Roberts, George W Lemaitre, Lawrence J Jasinski, Michael T Wijas, Peter R Gebauer and Trent G Kamke. View Insider Buying and Selling for LeMaitre Vascular.
Who bought LeMaitre Vascular stock? Who is buying LeMaitre Vascular stock?
LeMaitre Vascular's stock was acquired by a variety of institutional investors in the last quarter, including Conestoga Capital Advisors LLC, Concorde Asset Management LLC, Great West Life Assurance Co. Can, Eqis Capital Management Inc., Russell Investments Group Ltd., Capstone Asset Management Co., Thomson Horstmann & Bryant Inc. and Congress Asset Management Co. MA. View Insider Buying and Selling for LeMaitre Vascular.
How do I buy LeMaitre Vascular stock?
Shares of LeMaitre Vascular can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is LeMaitre Vascular's stock price today?
One share of LeMaitre Vascular stock can currently be purchased for approximately $28.40.
MarketBeat Community Rating for LeMaitre Vascular (NASDAQ LMAT)MarketBeat's community ratings are surveys of what our community members think about LeMaitre Vascular and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for LeMaitre Vascular (NASDAQ:LMAT) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | 5 Hold Ratings, 3 Buy Ratings |
| Consensus Rating: | Hold (Score: 2.38) |
| Consensus Price Target: | $25.71 (9.46% downside) |
Analysts' Ratings History for LeMaitre Vascular (NASDAQ:LMAT)
Show:
| Date | Firm | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
| 7/10/2017 | Canaccord Genuity | Downgrade | Buy -> Hold | $28.00 | High |  |
| 7/10/2017 | Benchmark Co. | Downgrade | Buy -> Hold | | High | |
| 6/6/2017 | Craig Hallum | Initiated Coverage | Hold | $31.00 | Low | |
| 4/28/2017 | Stifel Nicolaus | Boost Price Target | Buy | $25.00 -> $29.00 | Low | |
| 3/21/2017 | First Analysis | Initiated Coverage | Overweight -> Overweight | $29.00 | Low | |
| 2/22/2017 | Barrington Research | Downgrade | Outperform -> Market Perform | | N/A | |
| 9/22/2016 | Sidoti | Downgrade | Buy -> Neutral | $23.00 | N/A | |
| 7/28/2016 | Brean Capital | Boost Price Target | Buy | $17.50 -> $20.00 | N/A | |
| 5/3/2016 | Roth Capital | Boost Price Target | Buy | $18.00 -> $18.50 | N/A | |
| 12/7/2015 | Dougherty & Co | Boost Price Target | Buy | $16.00 -> $19.00 | N/A | |
(Data available from 7/27/2015 forward)
Earnings History for LeMaitre Vascular (NASDAQ:LMAT)Earnings History by Quarter for LeMaitre Vascular (NASDAQ LMAT)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 5/4/2017 | Q1 2017 | $0.13 | $0.16 | $23.48 million | $24.10 million | View | N/A | |
| 2/21/2017 | Q4 2016 | $0.15 | $0.13 | $23.70 million | $23.30 million | View | Listen | |
| 10/26/2016 | Q3 | $0.15 | $0.17 | $22.20 million | $19.00 million | View | Listen | |
| 7/27/2016 | Q2 | $0.11 | $0.14 | $21.59 million | $22.40 million | View | Listen | |
| 5/2/2016 | Q1 | $0.10 | $0.11 | $20.22 million | $20.26 million | View | Listen | |
| 2/24/2016 | Q415 | $0.09 | $0.13 | $20.10 million | $20.50 million | View | Listen | |
| 10/27/2015 | Q3 | $0.08 | $0.11 | $18.78 million | $19.03 million | View | Listen | |
| 7/28/2015 | Q2 | $0.07 | $0.10 | $18.90 million | $19.90 million | View | Listen | |
| 4/28/2015 | Q115 | $0.05 | $0.08 | $17.76 million | $18.90 million | View | Listen | |
| 2/25/2015 | Q314 | $0.07 | $0.11 | $18.90 million | $18.70 million | View | Listen | |
| 10/28/2014 | Q3 | $0.06 | $0.05 | $17.09 million | $17.50 million | View | Listen | |
| 2/25/2014 | Q4 | $0.05 | $0.05 | | | View | Listen | |
| 10/29/2013 | Q313 | $0.04 | $0.05 | $15.22 million | $15.30 million | View | Listen | |
(Data available from 1/1/2011 forward)
Earnings Estimates for LeMaitre Vascular (NASDAQ:LMAT)2017 EPS Consensus Estimate: $0.67
2018 EPS Consensus Estimate: $0.79
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
| Q1 2017 | 3 | $0.13 | $0.14 | $0.13 |
| Q2 2017 | 3 | $0.17 | $0.17 | $0.17 |
| Q3 2017 | 3 | $0.17 | $0.18 | $0.17 |
| Q4 2017 | 3 | $0.18 | $0.20 | $0.19 |
| Q1 2018 | 1 | $0.19 | $0.19 | $0.19 |
| Q2 2018 | 1 | $0.20 | $0.20 | $0.20 |
| Q3 2018 | 1 | $0.20 | $0.20 | $0.20 |
| Q4 2018 | 1 | $0.20 | $0.20 | $0.20 |
(Data provided by Zacks Investment Research)
Current Dividend Information for LeMaitre Vascular (NASDAQ:LMAT)| Most Recent Dividend: | 6/8/2017 |
| Annual Dividend: | $0.22 |
| Dividend Yield: | 0.77% |
| Payout Ratio: | 36.67% (Trailing 12 Months of Earnings)
31.43% (Based on This Year's Estimates)
27.16% (Based on Next Year's Estimates)
|
Dividend History by Quarter for LeMaitre Vascular (NASDAQ LMAT)| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
| 4/28/2017 | quarterly | $0.06 | 0.74% | 5/22/2017 | 5/24/2017 | 6/8/2017 |
| 2/23/2017 | quarterly | $0.06 | 1% | 3/20/2017 | 3/22/2017 | 4/6/2017 |
| 10/27/2016 | quarterly | $0.05 | 0.85% | 11/17/2016 | 11/21/2016 | 12/5/2016 |
| 7/29/2016 | quarterly | $0.05 | 1.05% | 8/18/2016 | 8/22/2016 | 9/6/2016 |
| 5/4/2016 | quarterly | $0.05 | 1.12% | 5/23/2016 | 5/25/2016 | 6/8/2016 |
| 2/25/2016 | quarterly | $0.05 | 1.19% | 3/17/2016 | 3/21/2016 | 4/4/2016 |
| 10/29/2015 | quarterly | $0.04 | 1.11% | 11/18/2015 | 11/20/2015 | 12/4/2015 |
| 7/29/2015 | quarterly | $0.04 | 1.25% | 8/18/2015 | 8/20/2015 | 9/3/2015 |
| 4/29/2015 | quarterly | $0.04 | 1.85% | 5/20/2015 | 5/22/2015 | 6/5/2015 |
| 2/26/2015 | quarterly | $0.04 | 2.03% | 3/18/2015 | 3/20/2015 | 4/3/2015 |
| 10/28/2014 | quarterly | $0.04 | 1.93% | 11/18/2014 | 11/20/2014 | 12/4/2014 |
| 7/31/2014 | quarterly | $0.04 | 1.73% | 8/19/2014 | 8/21/2014 | 9/4/2014 |
| 4/30/2014 | quarterly | $0.04 | 1.71% | 5/20/2014 | 5/22/2014 | 6/5/2014 |
| 2/26/2014 | quarterly | $0.04 | 1.75% | 3/18/2014 | 3/20/2014 | 4/3/2014 |
| 10/31/2013 | quarterly | $0.03 | 1.49% | 11/18/2013 | 11/20/2013 | 12/4/2013 |
| 7/30/2013 | quarterly | $0.03 | 1.73% | 8/19/2013 | 8/21/2013 | 9/4/2013 |
| 5/2/2013 | quarterly | $0.03 | 1.98% | 5/20/2013 | 5/22/2013 | 6/5/2013 |
| 2/27/2013 | quarterly | $0.03 | 1.92% | 3/18/2013 | 3/20/2013 | 4/3/2013 |
(Data available from 1/1/2013 forward)
Insider Trading and Institutional Ownership History for LeMaitre Vascular (NASDAQ:LMAT)Insider Ownership Percentage: 23.70%
Institutional Ownership Percentage: 66.45%
Insider Trades by Quarter for LeMaitre Vascular (NASDAQ:LMAT)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 6/1/2017 | Michael T Wijas | VP | Sell | 2,346 | $31.42 | $73,711.32 | |
| 5/24/2017 | Trent G Kamke | Insider | Sell | 15,780 | $30.28 | $477,818.40 | |
| 5/18/2017 | George W Lemaitre | Chairman | Sell | 21,225 | $30.11 | $639,084.75 | |
| 5/11/2017 | David B Roberts | Insider | Sell | 39,531 | $30.37 | $1,200,556.47 | |
| 5/10/2017 | George W Lemaitre | Chairman | Sell | 63,622 | $30.98 | $1,971,009.56 | |
| 5/9/2017 | George W Lemaitre | CEO | Sell | 34,517 | $30.67 | $1,058,636.39 | |
| 5/8/2017 | George W Lemaitre | CEO | Sell | 9,102 | $31.12 | $283,254.24 | |
| 5/4/2017 | David B Roberts | Insider | Sell | 44,340 | $31.14 | $1,380,747.60 | |
| 5/3/2017 | George W Lemaitre | Chairman | Sell | 87,342 | $32.35 | $2,825,513.70 | |
| 3/10/2017 | David B Roberts | Insider | Sell | 5,900 | $22.44 | $132,396.00 | |
| 3/1/2017 | George W Lemaitre | Chairman | Sell | 10,000 | $22.36 | $223,600.00 | |
| 2/28/2017 | George W Lemaitre | CEO | Sell | 3,000 | $22.27 | $66,810.00 | |
| 2/27/2017 | George W Lemaitre | CEO | Sell | 5,000 | $22.31 | $111,550.00 | |
| 9/16/2016 | David B Roberts | Insider | Sell | 6,452 | $21.05 | $135,814.60 | |
| 9/15/2016 | David B Roberts | Insider | Sell | 33,548 | $20.41 | $684,714.68 | |
| 9/8/2016 | George W Lemaitre | Chairman | Sell | 30,000 | $20.48 | $614,400.00 | |
| 9/7/2016 | David B Roberts | Insider | Sell | 20,000 | $20.07 | $401,400.00 | |
| 9/2/2016 | George W Lemaitre | Chairman | Sell | 60,037 | $18.30 | $1,098,677.10 | |
| 8/30/2016 | Peter R Gebauer | Insider | Sell | 3,431 | $18.20 | $62,444.20 | |
| 8/29/2016 | Peter R Gebauer | Insider | Sell | 26,815 | $17.78 | $476,770.70 | |
| 8/24/2016 | David B Roberts | Insider | Sell | 10,000 | $17.35 | $173,500.00 | |
| 8/24/2016 | George W Lemaitre | CEO | Sell | 6,800 | $17.49 | $118,932.00 | |
| 8/23/2016 | George W Lemaitre | CEO | Sell | 19,664 | $17.43 | $342,743.52 | |
| 8/22/2016 | George W Lemaitre | CEO | Sell | 8,927 | $17.39 | $155,240.53 | |
| 8/19/2016 | Cornelia W Lemaitre | Director | Sell | 5,000 | $17.15 | $85,750.00 | |
| 8/18/2016 | Cornelia W Lemaitre | Director | Sell | 22,500 | $17.36 | $390,600.00 | |
| 8/15/2016 | Cornelia W Lemaitre | Director | Sell | 22,500 | $17.36 | $390,600.00 | |
| 8/15/2016 | George W Lemaitre | Chairman | Sell | 15,896 | $17.53 | $278,656.88 | |
| 8/9/2016 | George W Lemaitre | Chairman | Sell | 5,460 | $17.41 | $95,058.60 | |
| 8/9/2016 | Lawrence J Jasinski | Director | Sell | 7,500 | $17.60 | $132,000.00 | |
| 8/5/2016 | David B Roberts | Insider | Sell | 10,000 | $17.63 | $176,300.00 | |
| 8/4/2016 | George W Lemaitre | Chairman | Sell | 4,540 | $17.65 | $80,131.00 | |
| 7/28/2016 | Peter R Gebauer | Insider | Sell | 30,000 | $16.47 | $494,100.00 | |
| 6/8/2016 | George W Lemaitre | CEO | Sell | 19,189 | $15.01 | $288,026.89 | |
| 6/7/2016 | George W Lemaitre | CEO | Sell | 9,100 | $15.02 | $136,682.00 | |
| 6/6/2016 | George W Lemaitre | CEO | Sell | 900 | $15.06 | $13,554.00 | |
| 6/6/2016 | Peter R Gebauer | Insider | Sell | 6,310 | $14.96 | $94,397.60 | |
| 6/3/2016 | Lawrence J Jasinski | Director | Sell | 4,924 | $14.99 | $73,810.76 | |
| 6/3/2016 | Trent G Kamke | Insider | Sell | 2,510 | $15.00 | $37,650.00 | |
| 5/25/2016 | Lawrence J Jasinski | Director | Sell | 6,326 | $15.30 | $96,787.80 | |
| 5/25/2016 | Trent G Kamke | Insider | Sell | 1,524 | $15.25 | $23,241.00 | |
| 5/23/2016 | Trent G Kamke | Insider | Sell | 16,465 | $15.02 | $247,304.30 | |
| 5/18/2016 | George W Lemaitre | CEO | Sell | 2,944 | $15.23 | $44,837.12 | |
| 5/17/2016 | Trent G Kamke | Insider | Sell | 2,400 | $15.51 | $37,224.00 | |
| 5/16/2016 | George W Lemaitre | CEO | Sell | 1,740 | $15.49 | $26,952.60 | |
| 5/13/2016 | George W Lemaitre | CEO | Sell | 7,451 | $15.45 | $115,117.95 | |
| 5/9/2016 | George W Lemaitre | CEO | Sell | 110,189 | $16.17 | $1,781,756.13 | |
| 5/6/2016 | David B Roberts | Director | Sell | 17,064 | $15.89 | $271,146.96 | |
| 5/5/2016 | Trent G Kamke | Insider | Sell | 3,327 | $16.10 | $53,564.70 | |
| 4/18/2016 | David B Roberts | Director | Sell | 1,766 | $16.10 | $28,432.60 | |
| 4/4/2016 | David B Roberts | Director | Sell | 17,444 | $15.99 | $278,929.56 | |
| 2/25/2016 | David B Roberts | Director | Sell | 2,690 | $15.91 | $42,797.90 | |
| 1/14/2016 | David B. Roberts | Director | Sell | 12,867 | $15.85 | $203,941.95 | |
| 1/11/2016 | David B Roberts | Director | Sell | 27,490 | $15.68 | $431,043.20 | |
| 1/8/2016 | David B Roberts | Director | Sell | 2,743 | $15.51 | $42,543.93 | |
| 12/9/2015 | Joseph P. Pellegrino, Jr. | CFO | Sell | 14,348 | $16.01 | $229,711.48 | |
| 12/4/2015 | Peter R. Gebauer | insider | Sell | 12,816 | $15.53 | $199,032.48 | |
| 12/1/2015 | Peter R. Gebauer | insider | Sell | 37,184 | $15.73 | $584,904.32 | |
| 11/25/2015 | David B. Roberts | Director | Sell | 10,000 | $15.96 | $159,600.00 | |
| 11/24/2015 | Cornelia W Lemaitre | Director | Sell | 41,135 | $15.61 | $642,117.35 | |
| 11/23/2015 | George W. Lemaitre | CEO | Sell | 65,052 | $15.63 | $1,016,762.76 | |
| 11/23/2015 | Joseph P. Pellegrino, Jr. | CFO | Sell | 45,840 | $15.57 | $713,728.80 | |
| 11/23/2015 | Peter R. Gebauer | insider | Sell | 11,971 | $15.31 | $183,276.01 | |
| 11/20/2015 | David B. Roberts | Director | Sell | 10,000 | $14.73 | $147,300.00 | |
| 11/20/2015 | Peter R. Gebauer | insider | Sell | 19,900 | $14.40 | $286,560.00 | |
| 11/17/2015 | George W Lemaitre | CEO | Sell | 30,000 | $14.15 | $424,500.00 | |
| 11/16/2015 | Lawrence J. Jasinski | Director | Sell | 7,500 | $13.57 | $101,775.00 | |
| 11/10/2015 | George W. Lemaitre | CEO | Sell | 57,844 | $13.80 | $798,247.20 | |
| 11/9/2015 | George W. Lemaitre | CEO | Sell | 7,524 | $13.70 | $103,078.80 | |
| 11/6/2015 | George W. Lemaitre | CEO | Sell | 39,000 | $13.83 | $539,370.00 | |
| 10/30/2015 | George W. Lemaitre | CEO | Sell | 16,190 | $14.55 | $235,564.50 | |
| 10/28/2015 | Peter R. Gebauer | insider | Sell | 44,315 | $13.97 | $619,080.55 | |
| 9/25/2015 | Peter R. Gebauer | insider | Sell | 5,441 | $13.91 | $75,684.31 | |
| 9/18/2015 | George W. Lemaitre | CEO | Sell | 46,391 | $14.37 | $666,638.67 | |
| 9/17/2015 | George W. Lemaitre | CEO | Sell | 49,559 | $13.96 | $691,843.64 | |
| 8/31/2015 | Peter R. Gebauer | insider | Sell | 10,465 | $13.49 | $141,172.85 | |
| 8/27/2015 | George W. Lemaitre | CEO | Sell | 28,700 | $13.66 | $392,042.00 | |
| 8/26/2015 | Peter R. Gebauer | insider | Sell | 15,978 | $13.53 | $216,182.34 | |
| 8/20/2015 | David B Roberts | Director | Sell | 12,000 | $13.58 | $162,960.00 | |
| 8/19/2015 | Peter R. Gebauer | insider | Sell | 4,022 | $14.24 | $57,273.28 | |
| 8/13/2015 | George W Lemaitre | CEO | Sell | 33,059 | $13.41 | $443,321.19 | |
| 5/19/2015 | Peter R Gebauer | Insider | Sell | 10,000 | $10.12 | $101,200.00 | |
| 5/18/2015 | George W Lemaitre | CEO | Sell | 20,132 | $10.01 | $201,521.32 | |
| 5/11/2015 | David B Roberts | Director | Sell | 15,000 | $10.31 | $154,650.00 | |
| 5/7/2015 | George W Lemaitre | CEO | Sell | 70,984 | $9.72 | $689,964.48 | |
| 5/6/2015 | David B Roberts | Director | Sell | 11,000 | $9.27 | $101,970.00 | |
| 4/29/2015 | Peter R Gebauer | Insider | Sell | 15,332 | $8.99 | $137,834.68 | |
| 4/16/2015 | Cornelia W Lemaitre | Director | Sell | 17,100 | $8.55 | $146,205.00 | |
| 4/14/2015 | Cornelia W Lemaitre | Director | Sell | 6,707 | $8.42 | $56,472.94 | |
| 3/31/2015 | Cornelia W Lemaitre | Director | Sell | 819 | $8.37 | $6,855.03 | |
| 3/30/2015 | Cornelia W Lemaitre | Director | Sell | 31 | $8.36 | $259.16 | |
| 3/25/2015 | Cornelia W Lemaitre | Director | Sell | 3,678 | $8.33 | $30,637.74 | |
| 3/24/2015 | Cornelia W Lemaitre | Director | Sell | 3,373 | $8.33 | $28,097.09 | |
| 3/23/2015 | Cornelia W Lemaitre | Director | Sell | 26,026 | $8.21 | $213,673.46 | |
| 3/18/2015 | Cornelia W Lemaitre | Director | Sell | 5,601 | $8.03 | $44,976.03 | |
| 3/10/2015 | Peter R Gebauer | Insider | Sell | 10,000 | $8.15 | $81,500.00 | |
| 3/9/2015 | Peter R Gebauer | Insider | Sell | 7,200 | $8.15 | $58,680.00 | |
| 3/6/2015 | Cornelia W Lemaitre | Director | Sell | 6,065 | $8.20 | $49,733.00 | |
| 3/3/2015 | David B Roberts | Director | Sell | 12,000 | $7.65 | $91,800.00 | |
| 1/29/2015 | Peter R Gebauer | Insider | Sell | 16,919 | $7.91 | $133,829.29 | |
| 1/26/2015 | George W Lemaitre | CEO | Sell | 3,486 | $7.85 | $27,365.10 | |
| 1/26/2015 | Peter R Gebauer | Insider | Sell | 1,800 | $7.90 | $14,220.00 | |
| 1/5/2015 | George W Lemaitre | CEO | Sell | 18,447 | $7.74 | $142,779.78 | |
| 1/2/2015 | David B Roberts | Director | Sell | 7,000 | $7.31 | $51,170.00 | |
| 12/30/2014 | George W Lemaitre | CEO | Sell | 18,067 | $7.58 | $136,947.86 | |
| 12/29/2014 | George W Lemaitre | CEO | Sell | 5,058 | $7.59 | $38,390.22 | |
| 12/26/2014 | George W Lemaitre | CEO | Sell | 6,693 | $7.53 | $50,398.29 | |
| 12/24/2014 | George W Lemaitre | CEO | Sell | 2,900 | $7.60 | $22,040.00 | |
| 12/10/2014 | George W Lemaitre | CEO | Sell | 1,117 | $7.40 | $8,265.80 | |
| 12/9/2014 | David B Roberts | Director | Sell | 3,000 | $7.36 | $22,080.00 | |
| 12/9/2014 | George W Lemaitre | CEO | Sell | 1,794 | $7.40 | $13,275.60 | |
| 11/28/2014 | George W Lemaitre | CEO | Sell | 42,641 | $7.40 | $315,543.40 | |
| 11/25/2014 | George W Lemaitre | CEO | Sell | 613 | $7.30 | $4,474.90 | |
| 11/13/2014 | Trent G Kamke | Insider | Sell | 1,100 | $7.15 | $7,865.00 | |
| 11/5/2014 | George W Lemaitre | CEO | Sell | 28,286 | $7.07 | $199,982.02 | |
| 10/31/2014 | David B Roberts | President | Sell | 3,500 | $7.03 | $24,605.00 | |
| 10/31/2014 | George W Lemaitre | CEO | Sell | 23,758 | $7.14 | $169,632.12 | |
| 9/8/2014 | George W Lemaitre | CEO | Sell | 29,966 | $7.10 | $212,758.60 | |
| 9/4/2014 | Lawrence J Jasinski | Director | Sell | 3,750 | $7.14 | $26,775.00 | |
| 6/25/2014 | Cornelia W Lemaitre | Director | Sell | 4,700 | $8.32 | $39,104.00 | |
| 5/7/2014 | David Roberts | President | Sell | 3,000 | $7.95 | $23,850.00 | |
| 3/7/2014 | Russell Hays | Director | Sell | 15,000 | $8.07 | $121,050.00 | |
| 3/6/2014 | Cornelia Lemaitre | Director | Sell | 6,950 | $8.15 | $56,642.50 | |
| 3/6/2014 | Trent Kamke | Insider | Sell | 1,278 | $8.18 | $10,454.04 | |
| 3/4/2014 | Cornelia Lemaitre | Director | Sell | 12,845 | $8.29 | $106,485.05 | |
| 1/23/2014 | Cornelia Lemaitre | Director | Sell | 3,900 | $8.24 | $32,136.00 | |
| 11/1/2013 | David B Roberts | Director | Sell | 2,000 | $7.96 | $15,920.00 | |
| 10/31/2013 | Cornelia W Lemaitre | Director | Sell | 20,000 | $7.88 | $157,600.00 | |
| 10/25/2013 | Cornelia W Lemaitre | Director | Sell | 20,000 | $7.38 | $147,600.00 | |
| 9/5/2013 | Joseph P Pellegrino Jr | CFO | Sell | 25,000 | $6.86 | $171,500.00 | |
| 9/3/2013 | David B Roberts | Director | Sell | 6,500 | $6.90 | $44,850.00 | |
| 8/14/2013 | Cornelia W Lemaitre | Director | Sell | 7,500 | $7.00 | $52,500.00 | |
| 8/12/2013 | Trent G Kamke | Insider | Sell | 2,000 | $6.90 | $13,800.00 | |
| 8/8/2013 | Trent G Kamke | Insider | Sell | 2,000 | $6.83 | $13,660.00 | |
| 8/2/2013 | Russell D Hays | Director | Sell | 15,000 | $6.78 | $101,700.00 | |
| 7/30/2013 | David B Roberts | Director | Sell | 12,403 | $6.85 | $84,960.55 | |
| 7/29/2013 | Cornelia W Lemaitre | Director | Sell | 2,500 | $7.00 | $17,500.00 | |
| 7/26/2013 | David B Roberts | Director | Sell | 9,100 | $6.77 | $61,607.00 | |
| 6/24/2013 | David B Roberts | Director | Sell | 2,100 | $6.75 | $14,175.00 | |
| 6/5/2013 | Robert V Linden | VP | Sell | 9,383 | $6.45 | $60,520.35 | |
| 5/30/2013 | Cornelia W Lemaitre | Director | Sell | 10,000 | $6.50 | $65,000.00 | |
| 11/27/2012 | Cornelia W Lemaitre | Director | Sell | 2,699 | $6.25 | $16,868.75 | |
| 8/10/2012 | George D Lemaitre | Director | Sell | 5,862 | $6.45 | $37,809.90 | |
(Data available from 1/1/2013 forward)
Headline Trends for LeMaitre Vascular (NASDAQ:LMAT)
Latest Headlines for LeMaitre Vascular (NASDAQ:LMAT)
| Source: |
|
| Date | Headline |
|---|
 | ETFs with exposure to LeMaitre Vascular, Inc. : July 24, 2017
finance.yahoo.com - July 25 at 2:54 AM |
 | LeMaitre Vascular, Inc. (LMAT) Given Consensus Rating of "Hold" by Analysts
www.americanbankingnews.com - July 18 at 10:34 PM |
| ETFs with exposure to LeMaitre Vascular, Inc. : July 14, 2017
finance.yahoo.com - July 15 at 6:01 AM |
| LeMaitre Vascular Will Announce Second Quarter 2017 Earnings Results on July 27, 2017
finance.yahoo.com - July 14 at 6:10 AM |
| LeMaitre Vascular, Inc. breached its 50 day moving average in a Bearish Manner : LMAT-US : July 11, 2017
finance.yahoo.com - July 12 at 2:22 AM |
 | LeMaitre Vascular Inc. (LMAT) Is Under Pressure In Early Trade
www.rttnews.com - July 11 at 5:23 AM |
| LeMaitre Vascular, Inc. (NASDAQ:LMAT) Cut to Hold at Canaccord Genuity
www.americanbankingnews.com - July 10 at 8:38 AM |
| LeMaitre Vascular, Inc. (NASDAQ:LMAT) Stock Rating Lowered by Benchmark Co.
www.americanbankingnews.com - July 10 at 7:50 AM |
| LeMaitre Vascular, Inc. (NASDAQ:LMAT) Expected to Post Quarterly Sales of $25.38 Million
www.americanbankingnews.com - July 8 at 10:30 AM |
| LeMaitre Vascular, Inc. (NASDAQ:LMAT) Expected to Announce Earnings of $0.17 Per Share
www.americanbankingnews.com - July 6 at 7:35 AM |
| ETFs with exposure to LeMaitre Vascular, Inc. : July 3, 2017
finance.yahoo.com - July 3 at 7:55 PM |
| LeMaitre Vascular, Inc. breached its 50 day moving average in a Bullish Manner : LMAT-US : June 26, 2017
finance.yahoo.com - June 27 at 12:05 AM |
| LeMaitre Vascular, Inc. (LMAT) Given Consensus Rating of "Buy" by Analysts
www.americanbankingnews.com - June 23 at 8:46 PM |
| LeMaitre Vascular, Inc. :LMAT-US: Earnings Analysis: Q1, 2017 By the Numbers : June 19, 2017
finance.yahoo.com - June 19 at 5:22 PM |
| ETFs with exposure to LeMaitre Vascular, Inc. : June 15, 2017
finance.yahoo.com - June 16 at 7:21 AM |
| LeMaitre Vascular, Inc. – Value Analysis (NASDAQ:LMAT) : June 15, 2017
finance.yahoo.com - June 16 at 7:21 AM |
| $25.38 Million in Sales Expected for LeMaitre Vascular, Inc. (LMAT) This Quarter
www.americanbankingnews.com - June 14 at 1:42 PM |
| LeMaitre Vascular, Inc. breached its 50 day moving average in a Bearish Manner : LMAT-US : June 14, 2017
finance.yahoo.com - June 14 at 10:24 AM |
| Zacks: Brokerages Anticipate LeMaitre Vascular, Inc. (LMAT) to Post $0.17 Earnings Per Share
www.americanbankingnews.com - June 12 at 8:38 AM |
| LeMaitre Vascular Inc (LMAT) Earns Hold Rating from Analysts at Craig Hallum
www.americanbankingnews.com - June 6 at 9:18 AM |
| Michael T. Wijas Sells 2,346 Shares of LeMaitre Vascular Inc (LMAT) Stock
www.americanbankingnews.com - June 2 at 8:42 PM |
| LeMaitre Vascular Inc (LMAT) Receives Average Rating of "Buy" from Brokerages
www.americanbankingnews.com - May 29 at 9:07 PM |
| LeMaitre Vascular Inc (LMAT) Insider Trent G. Kamke Sells 15,780 Shares
www.americanbankingnews.com - May 26 at 7:40 PM |
 | LeMaitre Vascular, Inc. (LMAT) Ex-Dividend Date Scheduled for May 22, 2017 - Nasdaq
www.nasdaq.com - May 20 at 12:02 AM |
| George W. Lemaitre Sells 21,225 Shares of LeMaitre Vascular Inc (LMAT) Stock
www.americanbankingnews.com - May 19 at 7:36 AM |
| $25.38 Million in Sales Expected for LeMaitre Vascular Inc (LMAT) This Quarter
www.americanbankingnews.com - May 17 at 9:46 AM |
| $0.17 Earnings Per Share Expected for LeMaitre Vascular Inc (LMAT) This Quarter
www.americanbankingnews.com - May 15 at 6:22 PM |
| Time to Focus on LeMaitre Vascular (LMAT) for Strong Earnings Growth Potential
finance.yahoo.com - May 15 at 10:37 AM |
| LeMaitre Vascular Inc (LMAT) Insider David B. Roberts Sells 39,531 Shares
www.americanbankingnews.com - May 12 at 7:21 PM |
| LeMaitre Vascular to Present at Upcoming Investor Conferences
finance.yahoo.com - May 11 at 6:48 PM |
| LeMaitre Vascular Inc (LMAT) CEO George W. Lemaitre Sells 9,102 Shares
www.americanbankingnews.com - May 10 at 11:26 PM |
| George W. Lemaitre Sells 34,517 Shares of LeMaitre Vascular Inc (LMAT) Stock
www.americanbankingnews.com - May 10 at 10:44 PM |
| LeMaitre Vascular Inc (LMAT) Chairman George W. Lemaitre Sells 63,622 Shares
www.americanbankingnews.com - May 10 at 10:44 PM |
| Can The Uptrend Continue for LeMaitre Vascular (LMAT)?
finance.yahoo.com - May 9 at 11:58 AM |
| LeMaitre Vascular Inc (LMAT) Insider David B. Roberts Sells 44,340 Shares
www.americanbankingnews.com - May 5 at 8:02 PM |
| LeMaitre Vascular Inc (LMAT) Chairman George W. Lemaitre Sells 87,342 Shares
www.americanbankingnews.com - May 5 at 8:10 AM |
| LeMaitre Vascular (LMAT) Earning Favorable Press Coverage, Report Shows
www.americanbankingnews.com - May 4 at 1:22 AM |
| LeMaitre Vascular Inc (LMAT) Receives Consensus Recommendation of "Buy" from Analysts
www.americanbankingnews.com - May 2 at 10:52 PM |
| Q2 2017 EPS Estimates for LeMaitre Vascular Inc Increased by First Analysis (LMAT)
www.americanbankingnews.com - May 2 at 8:36 AM |
| Barrington Research Analysts Increase Earnings Estimates for LeMaitre Vascular Inc (LMAT)
www.americanbankingnews.com - May 1 at 9:50 AM |
| LeMaitre Vascular (LMAT) Receiving Somewhat Favorable Media Coverage, AlphaOne Reports
www.americanbankingnews.com - April 30 at 5:20 PM |
| LeMaitre Vascular Inc (LMAT) Given "Buy" Rating at Stifel Nicolaus
www.americanbankingnews.com - April 29 at 12:46 PM |
| LeMaitre Vascular Inc (LMAT) Raised to Buy at Zacks Investment Research
www.americanbankingnews.com - April 29 at 9:26 AM |
| FY2018 EPS Estimates for LeMaitre Vascular Inc (LMAT) Boosted by Analyst
www.americanbankingnews.com - April 28 at 11:33 PM |
| LeMaitre Vascular Inc Plans Quarterly Dividend of $0.06 (LMAT)
www.americanbankingnews.com - April 28 at 10:46 PM |
| LeMaitre Vascular, Inc.: Leads amongst peers with strong fundamentals
finance.yahoo.com - April 28 at 7:13 PM |
 | Top Ranked Momentum Stocks to Buy for April 28th
www.zacks.com - April 28 at 9:32 AM |
| Company Spotlight: LeMaitre
www.rttnews.com - April 28 at 9:32 AM |
| LeMaitre Vascular's (LMAT) Buy Rating Reiterated at Canaccord Genuity
www.americanbankingnews.com - April 27 at 10:44 PM |
| Somewhat Positive Media Coverage Very Likely to Affect LeMaitre Vascular (LMAT) Share Price
www.americanbankingnews.com - April 27 at 8:24 PM |
LeMaitre Vascular (LMAT) Chart for Thursday, July, 27, 2017
